{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T06:25:57Z","timestamp":1745216757940},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,13]],"date-time":"2012-03-13T00:00:00Z","timestamp":1331596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biometals"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10534-012-9536-8","type":"journal-article","created":{"date-parts":[[2012,3,12]],"date-time":"2012-03-12T07:21:23Z","timestamp":1331536883000},"page":"563-568","source":"Crossref","is-referenced-by-count":14,"title":["Calcium channel blocker use and serum ferritin in adults with hypertension"],"prefix":"10.1007","volume":"25","author":[{"given":"Arch G.","family":"Mainous III","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene D.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa A.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharleen P.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary M.","family":"Hulihan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Althea M.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,13]]},"reference":[{"key":"9536_CR1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/jcp.25.4.326","volume":"25","author":"GM Addison","year":"1972","unstructured":"Addison GM, Beamish MR, Hales CN, Hodgkins M, Jacobs A, Llewellin P (1972) An immunoradiometric assay for ferritin in the serum of normal patients and patients with iron deficiency and iron overload. J Clin Pathol 25:326\u2013329","journal-title":"J Clin Pathol"},{"key":"9536_CR2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ajh.10348","volume":"73","author":"TB Chaston","year":"2003","unstructured":"Chaston TB, Richardson DR (2003) Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity. Am J Hematol 73:200\u2013210","journal-title":"Am J Hematol"},{"key":"9536_CR3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2010.03.083","volume":"56","author":"P Gujja","year":"2010","unstructured":"Gujja P, Rosing DR, Tripodi DJ, Shizukuda Y (2010) Iron overload cardiomyopathy: better understanding of an increasing disorder. J Am Coll Cardiol 56:1001\u20131012","journal-title":"J Am Coll Cardiol"},{"key":"9536_CR4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm1542","volume":"13","author":"S Ludwiczek","year":"2007","unstructured":"Ludwiczek S, Theurl I, Muckenthaler MU et al (2007) Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1. Nat Med 13:448\u2013454","journal-title":"Nat Med"},{"key":"9536_CR5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1370\/afm.1262","volume":"9","author":"EM Matheson","year":"2011","unstructured":"Matheson EM, Mainous AG 3rd, Everett CJ, King DE (2011) Tea and coffee consumption and MRSA nasal carriage. Ann Fam Med 9:299\u2013304","journal-title":"Ann Fam Med"},{"key":"9536_CR6","first-page":"131","volume-title":"Handbook of radioimmunoassay","author":"L Miles","year":"1977","unstructured":"Miles L (1977) Measurement of serum ferritin by a 2-site immunoradiometric assay. In: Abraham G (ed) Handbook of radioimmunoassay. Marcel Dekker, New York, pp 131\u2013177"},{"key":"9536_CR7","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cardfail.2010.05.009","volume":"16","author":"CJ Murphy","year":"2010","unstructured":"Murphy CJ, Oudit GY (2010) Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment. J Card Fail 16:888\u2013900","journal-title":"J Card Fail"},{"key":"9536_CR8","unstructured":"National Center for Health Statistics, Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. Data Sets and Related Documentation. Available at: http:\/\/www.cdc.gov\/nchs\/nhanes.htm . Accessed 10 Oct 2011"},{"key":"9536_CR9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1056\/NEJM198101153040311","volume":"304","author":"AW Nienhuis","year":"1981","unstructured":"Nienhuis AW (1981) Vitamin C and iron. N Engl J Med 304:170\u2013171","journal-title":"N Engl J Med"},{"key":"9536_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1749-6632.1974.tb20588.x","volume":"232","author":"RT O\u2019Brien","year":"1974","unstructured":"O\u2019Brien RT (1974) Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major. Ann NY Acad Sci 232:221\u2013225","journal-title":"Ann NY Acad Sci"},{"key":"9536_CR11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trsl.2010.11.002","volume":"157","author":"M Otto-Duessel","year":"2011","unstructured":"Otto-Duessel M, Brewer C, Wood JC (2011) Interdependence of cardiac iron and calcium in a murine model of iron overload. Transl Res. 157:92\u201399","journal-title":"Transl Res."},{"key":"9536_CR12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm920","volume":"9","author":"GY Oudit","year":"2003","unstructured":"Oudit GY, Sun H, Trivieri MG, Koch SE et al (2003) L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 9:1187\u20131194","journal-title":"Nat Med"},{"key":"9536_CR13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-143-7-200510040-00010","volume":"143","author":"Qaseem A, Aronson M, Fitterman N, Snow V, Weiss KB, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians","year":"2005","unstructured":"Qaseem A, Aronson M, Fitterman N, Snow V, Weiss KB, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians (2005) Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians. Ann Intern Med 143:517\u2013521","journal-title":"Ann Intern Med"},{"key":"9536_CR14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7326\/0003-4819-143-7-200510040-00011","volume":"143","author":"B Schmitt","year":"2005","unstructured":"Schmitt B, Golub RM, Green R (2005) Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians. Ann Intern Med 143:522\u2013536","journal-title":"Ann Intern Med"},{"key":"9536_CR15","unstructured":"U.S. Preventive Services Task Force. Screening for Hemochromatosis. August 2006. Available at: http:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/uspshemoch.htm . Accessed 10 Oct 2011"},{"key":"9536_CR16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1211\/jpp.58.5.0001","volume":"58","author":"ED Weinberg","year":"2006","unstructured":"Weinberg ED (2006) Therapeutic potential of iron chelators in diseases associated with iron mismanagement. J Pharm Pharmacol 58:575\u2013584","journal-title":"J Pharm Pharmacol"},{"key":"9536_CR17","first-page":"732","volume":"2","author":"ED Weinberg","year":"2010","unstructured":"Weinberg ED (2010) The hazards of iron loading. Metallomics 2:732\u2013740","journal-title":"The hazards of iron loading. Metallomics"}],"container-title":["BioMetals"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-012-9536-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10534-012-9536-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-012-9536-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:11:45Z","timestamp":1559232705000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10534-012-9536-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,13]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9536"],"URL":"https:\/\/doi.org\/10.1007\/s10534-012-9536-8","relation":{},"ISSN":["0966-0844","1572-8773"],"issn-type":[{"value":"0966-0844","type":"print"},{"value":"1572-8773","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,13]]}}}